The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.
This single-arm, open-label clinical trial will test the feasibility, usability, acceptability, and preliminary efficacy of a digital therapeutic in reducing binge eating and weight in 30 adults with comorbid recurrent binge eating and obesity.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Evidence-based treatments for obesity and binge eating
System Usability Sale (SUS)
The SUS and a semi-structured user feedback interview will be utilized to systematically capture usability and acceptability.
Time frame: Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.